Science Advances-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0 经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0 经验分享：前前后后7个月，和别人合作的工作 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv 认真修改后返回 一个月后接受 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]

2020-05-25 ms6437770273944149

审稿速度:1.0
经验分享：2019.05.24 transferred

472 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0 经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0 经验分享：前前后后7个月，和别人合作的工作 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv 认真修改后返回 一个月后接受 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]

2020-09-09 你好，阿蒙

投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大

499 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0 经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0 经验分享：前前后后7个月，和别人合作的工作 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv 认真修改后返回 一个月后接受 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]

2020-05-17 ms3136433039918945

审稿速度:2.0
经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。

432 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0 经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0 经验分享：前前后后7个月，和别人合作的工作 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv 认真修改后返回 一个月后接受 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]

2019-04-12 ms4270311197517729

审稿速度:1.0 | 投稿命中率:75.0
经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊

256 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0 经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0 经验分享：前前后后7个月，和别人合作的工作 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv 认真修改后返回 一个月后接受 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]

2021-07-01 大药

偏重的研究方向：生物化学
经验分享：投稿到拒稿只用了4天，快乐！

329 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0 经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0 经验分享：前前后后7个月，和别人合作的工作 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv 认真修改后返回 一个月后接受 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]

2020-06-04 jurryz

审稿速度:6.0 | 投稿命中率:25.0
经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。

425 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0 经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0 经验分享：前前后后7个月，和别人合作的工作 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv 认真修改后返回 一个月后接受 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]

2020-09-22 James SUN

审稿速度:2.0
经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。

330 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0 经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0 经验分享：前前后后7个月，和别人合作的工作 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv 认真修改后返回 一个月后接受 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]

2021-07-30 1de7d16fm61(暂无匿称)

无

211 0

[GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0 经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0 经验分享：前前后后7个月，和别人合作的工作 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv 认真修改后返回 一个月后接受 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]

2020-05-29 尊严

对创新性的要求还是要比NC高的

363 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=860949, encodeId=41128609490c, content=审稿速度:1.0 经验分享：2019.05.24 transferred , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Mon May 25 10:23:32 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883760, encodeId=5c5c883e6091, content= 投SCIENCE TRANSLATIONAL MEDICINE被拒，建议转投此杂志，不知机会大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211006/298c300ad56d42b6a130908b27e6c26d/fc5b8fd50ac144f3973fdc4b334d8e25.jpg, createdBy=2bb42569605, createdName=你好，阿蒙, createdTime=Wed Sep 09 01:21:16 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860672, encodeId=a6858606e246, content=审稿速度:2.0 经验分享：最根正苗红的science子刊，稿源几乎都是science正刊转过去的，所以不冲击cns的文章，就基本不要投这个杂志了，极低的接收率。审稿超快，审稿意见基本20天内能返回。貌似要过3-4个独立编辑的手。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Sun May 17 21:49:22 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850773, encodeId=32bb850e7345, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿三周了，一直在编辑那，反复邀请编辑，再评估，现在又是邀请编辑，大家有类似的吗？感觉要凉啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43375414153, createdName=ms4270311197517729, createdTime=Fri Apr 12 17:01:54 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978565, encodeId=6b889e856566, content=偏重的研究方向：生物化学 经验分享：投稿到拒稿只用了4天，快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1b35512140, createdName=大药, createdTime=Thu Jul 01 11:07:35 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601337, encodeId=ba1260133e43, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志真不靠谱，投稿两个多月，换了几个编辑，最后没送审直接拒了。效率极低，耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ztLHSarrwfOxbw2WGK8AvWRfUlNGpox5ZAd4d306Fyt8IJ74jVsx5AFKXzgmazgF44vyNm25iaF8A/0, createdBy=2e152100215, createdName=jurryz, createdTime=Thu Jun 04 10:45:49 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887481, encodeId=c72288e481a8, content=审稿速度:2.0 经验分享：课题被抢发到了JCI, 我们投立刻JCI被拒绝，19年9月投稿，12月接收，20年2月见刊。期间三个审稿人给了非常专业的问题，一一认真回答后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6811738319, createdName=James SUN, createdTime=Tue Sep 22 21:20:47 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004087, encodeId=fac6100408e68, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=343c1700350, createdName=1de7d16fm61(暂无匿称), createdTime=Fri Jul 30 22:22:13 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600825, encodeId=643d6008254d, content=对创新性的要求还是要比NC高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Fri May 29 17:09:24 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860321, encodeId=45ec860321da, content=审稿速度:7.0 经验分享：前前后后7个月，和别人合作的工作 三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv 认真修改后返回 一个月后接受 还没有online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Thu May 07 23:11:38 CST 2020, time=2020-05-07, status=1, ipAttribution=)]

2020-05-07 ms4608271349787965

审稿速度:7.0
经验分享：前前后后7个月，和别人合作的工作
三个审稿人，两个大修，一个说文章更适合催化剂类的，不适合sci adv
认真修改后返回
一个月后接受
还没有online

214 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务